The Latest Breaking News from Kritika SarmahHer

The first-quarter performance of The Charles Schwab Corporation (SCHW) has attracted considerable investor attention. But what lies beneath the surface? Let's dissect its fundamentals to ascertain whether it presents an enticing buying opportunity amidst today's market intricacies.

As technological advancements and investments increase, the chip industry anticipates significant benefits. While industry giants NVIDIA (NVDA) and Taiwan Semiconductor Manufacturing Company (TSM) are poised to capitalize on industry tailwinds, let's analyze which of these stocks is set for success in the second quarter.

The biotech sector is primed for growth, fueled by a surge in FDA approvals, anticipated M&A deals, and the integration of AI in drug discovery. So, fundamentally sound biotech stocks Theratechnologies (THTX), Harmony Biosciences (HRMY), and Shionogi & Co. (SGIOY) might be solid buys in this month. Keep reading.

In the dynamic landscape of semiconductor investments, two prominent industry players, Advanced Micro Devices (AMD) and QUALCOMM (QCOM), vie for investor attention. With the semiconductor industry poised for substantial growth driven by robust chip demand across diverse sectors and bolstered by supportive government initiatives, both companies stand to benefit. However,…

As pharma titan Johnson & Johnson (JNJ) gears up to unveil its first-quarter results on April 16, 2024, anticipation looms over the pharmaceutical industry. JNJ’s recent acquisitions signal the company’s strategic expansions, and given its history as one of the prominent pharma companies, is JNJ’s forecast as stunning? Let us…

Leading healthcare company UnitedHealth Group (UNH) is poised to release its first-quarter financial results on April 16, 2024. Despite UNH's recent cyber-attack misery, its acquisition of Stewardship Health signals expansion. So, should investors Buy or Wait? Keep reading to know more….

This year, the automotive industry is likely to accelerate with soaring electric vehicle sales and infrastructure advancements. Hence, quality auto stocks Bayerische Motoren Werke (BMWYY), Volkswagen (VWAGY), and REV Group (REVG), which boast lower-than-industry valuation multiples, might be solid buys for April. Keep reading.

Amidst the ever-changing digital terrain and the ascent of artificial intelligence (AI), the future looks promising for tech behemoths Alphabet (GOOGL) and Amazon.com (AMZN). Yet, a pressing query looms: Can GOOGL and AMZN uphold their status as reigning tech stock champions this year? Let's delve deeper to uncover the answer.

The technology sector is undergoing a notable surge, propelled by increasing digitalization endeavors among businesses and governmental support for technological progress. So, fundamentally sound tech stocks Box Inc. (BOX), Teradata (TDC), and Materialise (MTLS), which seem pretty undervalued, might be ideal buys this month. Continue reading.

This year, the biotech industry anticipates a resurgence with increased M&A, FDA approvals, and AI-driven innovations. Given the industry’s rosy prospects, biotech stocks BioMarin Pharmaceutical (BMRN), ANI Pharmaceuticals (ANIP), and Genmab A/S (GMAB), gaining significant altitude and interest, could be ideal buys. Read on.

Rising oil prices due to escalating geopolitical tensions and supply concerns should bode well for the energy sector. So, I think fundamentally solid energy stocks Energy Transfer (ET), Pembina Pipeline (PBA), and Matrix Service (MTRX) might be ideal buys. Read more.